Article info

Download PDFPDF
Original research
Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims

Authors

  1. Correspondence to Dr Stefano Malinverni, Emergency Medicine, CHU Saint-Pierre, Bruxelles, Belgium; stefano_malinverni{at}stpierre-bru.be
View Full Text

Citation

Malinverni S, Bédoret F, Bartiaux M, et al
Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims

Publication history

  • Received July 22, 2020
  • Revised September 17, 2020
  • Accepted September 27, 2020
  • First published October 26, 2020.
Online issue publication 
July 19, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.